Amylyx drug helps slow ALS progression in mid-stage study
Privately held drug developer Amylyx Pharmaceuticals Inc said on Tuesday its experimental therapy to treat amyotrophic lateral sclerosis (ALS) helped slow the progression of the fatal neurological disorder in a mid-stage study. (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Top 10 Health Questions America Asked Dr. Google In 2019
(CNN) — Google users in the United States had a lot of questions about blood pressure, the keto diet and hiccups in 2019. Those topics were among the 10 most-searched health-related questions on the search engine this year, according to new data from Google. The list was based on search terms collected between January and early December. Last year, the top health-related questions Googled by people in the US included what is amyotrophic lateral sclerosis, or ALS, what is endometriosis and how long does weed stay in your urine. In 2017, what is lupus, how long does the flu last and what causes hiccups were some of the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 12, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Google Source Type: news

Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis
(Mary Ann Liebert, Inc./Genetic Engineering News) The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including neuroregenerative therapy and treatment for amyotrophyic lateral sclerosis (ALS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2019 Category: International Medicine & Public Health Source Type: news

FDA Clears Oral Film Formulation of ALS Drug Riluzole (Exservan) FDA Clears Oral Film Formulation of ALS Drug Riluzole (Exservan)
An oral film formulation of riluzole may help overcome challenges of disease-related dysphagia in patients with amyotrophic lateral sclerosis.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 26, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA Approves Exservan (riluzole) Oral Film for the Treatment of Amyotrophic Lateral Sclerosis
WARREN, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 25, 2019 Category: Drugs & Pharmacology Source Type: news

FDA approves Aquestive's ALS treatment
The U.S. Food and Drug Administration on Friday approved http://bit.ly/2pIFzi5 Aquestive Therapeutics' treatment for neurological disorder amyotrophic lateral sclerosis (ALS). (Source: Reuters: Health)
Source: Reuters: Health - November 22, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer's disease - Isaev NK, Stelmashook EV, Genrikhs EE.
The disruption of homeostasis of zinc (Zn2+) and copper (Cu2+) ions in the central nervous system is involved in the pathogenesis of many neurodegenerative diseases, such as amyotrophic lateral sclerosis, Wilson's, Creutzfeldt-Jakob, Parkinson's, and Alzhe... (Source: SafetyLit)
Source: SafetyLit - November 22, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Molecular mechanisms linking ALS/FTD and psychiatric disorders, the potential effects of lithium - Limanaqi F, Biagioni F, Ryskalin L, Busceti CL, Fornai F.
Altered proteostasis, endoplasmic reticulum (ER) stress, abnormal unfolded protein response (UPR), mitochondrial dysfunction and autophagy impairment are interconnected events, which contribute to the pathogenesis of amyotrophic lateral sclerosis (ALS)/fro... (Source: SafetyLit)
Source: SafetyLit - November 9, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Pelosi ’s radical plan would leave ALS patients behind
Last month, House Speaker Nancy Pelosi unveiled aradical drug pricing plan, H.R. 3, that could jeopardize the development of innovative treatments for some of the most challenging diseases and leave U.S. patients behind. For example,researchers are focused every day on finding new treatments and cures for amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig ’s Disease), but Pelosi’s plan could threaten future treatments for ALS by imposing government-set prices on critical medicines, creating increased uncertainty and eroding incentives for investment into risky research and development (R&D). (Source: The Catalyst)
Source: The Catalyst - October 15, 2019 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Research and Development ALS Source Type: news

ICYMI: Fighting for a cure to ALS
Yesterday at The Atlantic Festival, I had the chance to speak with Amy, a biopharmaceutical researcher focused on amyotrophic lateral sclerosis (ALS). As a young girl, Amy ’s father inspired her to become a scientist. Years later, his ALS diagnosis made her life’s work personal. (Source: The Catalyst)
Source: The Catalyst - September 25, 2019 Category: Pharmaceuticals Authors: Anne McDonald Pritchett, PhD Tags: Research and Development ALS Rare Diseases GoBoldly Source Type: news

Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry
Clinical / Medical (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 25, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Biohaven's Verdiperstat, An Oral Myeloperoxidase Inhibitor, Selected For Platform Trial Collaboration At Massachusetts General Hospital's Healey and AMG Center For Amyotrophic Lateral Sclerosis (ALS)
NEW HAVEN, Conn., Sept. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company"), a clinical stage biopharmaceutical company with a portfolio of late-... Biopharmaceuticals, Neurology Biohaven Pharmaceutical, verdiperstat, Amyotrophic Lateral Sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 18, 2019 Category: Pharmaceuticals Source Type: news

Is This a Fasciculation?
Discussion Benign fasciculations are very common and occur in up to 70% of the general population. They occur at different points in people’s lives. They can be brought out by stress, poor sleep hygiene and caffeine. Caffeine has numerous uses especially for regulating sleep and attention. However too much can cause restlessness, jitteriness and sleep deprivation too. The recommended amount of caffeine for a teenager is
Source: PediatricEducation.org - September 16, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

US WorldMeds lands new FDA approval
Louisville-based pharmaceutical company US WorldMeds LLC received Food and Drug Administration approval for a new use of its drug Myobloc. Myobloc can now be used to treat sialorrhea, commonly known as drooling. It's a common and unfortunate symptom that follows many neurological disorders such as Parkinson's Disease, amyotrophic lateral sclerosis (ALS), cerebral palsy and stroke to name a few. "We are committed to helping patients who struggle with confidence due to their sialorrhea," US WorldMeds… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2019 Category: Pharmaceuticals Authors: Chris Larson Source Type: news

US WorldMeds lands new FDA approval
Louisville-based pharmaceutical company US WorldMeds LLC received Food and Drug Administration approval for a new use of its drug Myobloc. Myobloc can now be used to treat sialorrhea, commonly known as drooling. It's a common and unfortunate symptom that follows many neurological disorders such as Parkinson's Disease, amyotrophic lateral sclerosis (ALS), cerebral palsy and stroke to name a few. "We are committed to helping patients who struggle with confidence due to their sialorrhea," US WorldMeds… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 28, 2019 Category: Biotechnology Authors: Chris Larson Source Type: news

Socialized medicine in Canada: No money to keep you alive, but plenty of government funds to help you commit suicide
(Natural News) The Canadian medical system has a smart way of saving money: helping people commit suicide when their care becomes too costly. This sickening truth about the country’s socialized medicine was recently illustrated by the case of a 41-year-old British Columbia man, Sean Tagert, who had been living with amyotrophic lateral sclerosis, or ALS.... (Source: NaturalNews.com)
Source: NaturalNews.com - August 22, 2019 Category: Consumer Health News Source Type: news

Eye-controlled, power wheelchair performs well for ALS patients - Elliott MA, Malvar H, Maassel LL, Campbell J, Kulkarni H, Spiridonova I, Sophy N, Beavers J, Paradiso A, Needham C, Rifley J, Duffield M, Crawford J, Wood B, Cox EJ, Scanlan JM.
INTRODUCTION: Our pilot study tested the feasibility and performance of an eye-controlled power wheelchair for amyotrophic lateral sclerosis (ALS) patients. METHODS: In this prospective pilot study, participants drove the wheelchair three times aro... (Source: SafetyLit)
Source: SafetyLit - August 12, 2019 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Motor neurone disease researchers find link to microbes in gut
Study could eventually lead to new treatments for neurodegenerative conditionScientists have found tantalising clues that the devastating condition motor neurone disease may be linked to changes in microbes that live in the gut.Studies in mice revealed that animals bred to develop amyotrophic lateral sclerosis (ALS), a form of the disease that affectedthe cosmologist Stephen Hawking, improved and lived longer when they were given an organism calledAkkermansia muciniphila.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 22, 2019 Category: Science Authors: Ian Sample Science editor Tags: Motor neurone disease Medical research Science Society Microbiology Source Type: news

Molecular 'clutch' puts infection-fighting cells into gear
(National Centre for Biological Sciences) An international team including University of Warwick scientists identifies proteins that drive activation of our immune response. Adaptor proteins act as a 'clutch' to move clusters of proteins within cellsCould open opportunities to design immune cells to combat specific problems. Protein condensates are involved; have been found to play roles in many biological processes and diseases, including Huntington's disease, amyotrophic lateral sclerosis, and types of cancer. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 22, 2019 Category: Biology Source Type: news

Biohaven's treatment for Lou Gehrig's disease fails to win FDA nod
Biohaven Pharmaceutical Holding Co Ltd said on Friday the U.S. health regulator failed to approve its treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, sending its shares down nearly 6% in extended trading. (Source: Reuters: Health)
Source: Reuters: Health - July 20, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Taking out the protein garbage becomes more difficult as neurons age
(University of Pennsylvania School of Medicine) As cells age, their ability to shed harmful refuse declines. New research suggests that the deterioration of autophagy in aged neurons could be a risk factor for a suite of neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis), Alzheimer's, and Parkinson's. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 19, 2019 Category: International Medicine & Public Health Source Type: news

Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors
GERMANTOWN, Md., July 18, 2019 -- (Healthcare Sales & Marketing Network) -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, a... Biopharmaceuticals, Regenerative Medicine, Personnel Neuralstem, Amyotrophic Lateral Sclerosis, spinal cord injury, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 18, 2019 Category: Pharmaceuticals Source Type: news

Higher BMI Linked to Lower ALS Risk Higher BMI Linked to Lower ALS Risk
The hypothesis that high body mass index guards against development of amyotrophic lateral sclerosis is reinforced by new research.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 3, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

An efficient gait dynamics classification method for neurodegenerative diseases using brain signals - Mole SSS, Sujatha K.
Neurons of the human brain are primarily affected by the Huntington's disease (HD), Amyotrophic Lateral Sclerosis (ALS), Parkinson's disease and so on. Classification of these neurodegenerative diseases (NDD) is clinically important to analyze the destruct... (Source: SafetyLit)
Source: SafetyLit - June 30, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

High BMI, Weight Gain Linked to Lasting Decrease in ALS Risk
THURSDAY, June 27, 2019 -- High body mass index (BMI) and weight gain are associated with a reduced long-term risk for amyotrophic lateral sclerosis (ALS), according to a study published online June 26 in Neurology. Ola Nakken, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 27, 2019 Category: Pharmaceuticals Source Type: news

Protein offers protection against nerve degeneration in ALS model
(Boston University School of Medicine) Increasing the levels of the anti-aging protein hormone Klotho improves the neurological deficits and prolongs life span in an experimental model with Amyotrophic Lateral Sclerosis (ALS). In addition, brain immune cells called microglia play an important role in protecting the brain against inflammation and, likely, motor neuron loss in this model. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 27, 2019 Category: International Medicine & Public Health Source Type: news

Could Heavier Folks Be at Lower Risk for ALS?
WEDNESDAY, June 26, 2019 -- It's not often that anything good is associated with obesity. Yet heavy folks and those who bulk up as they age may have less risk for the deadly disease amyotrophic lateral sclerosis (ALS), a new study finds. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 26, 2019 Category: General Medicine Source Type: news

Change TV Channel Using Your Eyes with Xfinity X1 Eye Control
Xfinity X1 users with disabilities like spinal cord injuries or amyotrophic lateral sclerosis (ALS) can now use their eyes to change channels, set a recording or search for shows (Source: Disabled World)
Source: Disabled World - June 19, 2019 Category: Disability Tags: Electronics/Software Source Type: news

ALS research reveals new treatment approach
(Sanford Burnham Prebys Medical Discovery Institute) New research on amyotrophic lateral sclerosis (AML) has revealed that a protein called membralin plays a key role in the disease process. The study, published in Journal of Clinical Investigation, suggests that membralin-boosting gene therapy is a potential therapeutic direction to treat this often deadly disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 23, 2019 Category: Biology Source Type: news

Experimental Agent Shows Promise in Slowing Genetic Form of ALS Experimental Agent Shows Promise in Slowing Genetic Form of ALS
Researchers successfully target elevated levels of a harmful protein, offering hope to people with a genetic form of amyotrophic lateral sclerosis.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 3, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Pluripotency or differentiation -- That is the question
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) Induced pluripotent stem cells can turn into any type of cell in the body or remain in their original form. In Molecular Cell, scientists from the Helmholtz Zentrum M ü nchen describe how cells 'decide' which of these two directions to take. During their research, they identified a protein and a ribonucleic acid (RNA) that play a highly significant role in this process. Their discovery also allows a better understanding of amyotrophic lateral sclerosis (ALS)*. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 2, 2019 Category: International Medicine & Public Health Source Type: news

Experimental treatment could be 'game-changing' for genetic ALS, experts say
An experimental treatment for the rapidly progressive disease ALS, or amyotrophic lateral sclerosis, has been called potentially "game-changing." (Source: CNN.com - Health)
Source: CNN.com - Health - May 1, 2019 Category: Consumer Health News Source Type: news

Scientists Create Speech From Brain Signals
A prosthetic voice decodes what the brain intends to say and generates (mostly) understandable speech, no muscle movement needed. (Source: NYT Health)
Source: NYT Health - April 24, 2019 Category: Consumer Health News Authors: BENEDICT CAREY Tags: Stroke Brain Epilepsy Amyotrophic Lateral Sclerosis Emory University Georgia Institute of Technology Mayo Clinic Nature (Journal) University of California, Berkeley University of California, San Francisco Bauby, Jean-Dominique your-f Source Type: news

Scientists create decoder to turn brain activity into speech
Technology could in effect give voice back to people with conditions such as Parkinson ’sScientists have developed a decoder that can translate brain activity directly into speech.In future the brain-machine interface could restore speech to people who have lost their voice through paralysis and conditions such as throat cancer, amyotrophic lateral sclerosis (ALS) and Parkinson ’s disease.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 24, 2019 Category: Science Authors: Hannah Devlin Science correspondent Tags: Medical research Neuroscience Cancer Parkinson's disease Health Society Source Type: news

African-Americans With ALS Survive Longer Than Caucasians
MONDAY, April 22, 2019 -- For people with amyotrophic lateral sclerosis (ALS), African-Americans have longer survival than Caucasians when death is the outcome, but not when the outcome is death or tracheostomy and invasive ventilation (TIV),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2019 Category: Pharmaceuticals Source Type: news

Research reveals how the most common ALS mutation dooms cells
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital scientists have cracked the mystery surrounding the most common genetic cause of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. The research suggests possible new approaches to diagnosis and treatment of the lethal disorder. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 10, 2019 Category: International Medicine & Public Health Source Type: news

Biochemical switches identified that could be triggered to treat muscle, brain disorders
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital scientists have found that the enzymes ULK1 and ULK2 play a key role in breaking down cell structures called stress granules, whose persistence leads to toxic buildup of proteins that kill muscle and brain cells. Such buildup is central to the pathology of three related diseases: inclusion body myopathy (IBM), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 10, 2019 Category: International Medicine & Public Health Source Type: news

Researchers reveal novel therapeutic strategy for ALS
(Chinese Academy of Sciences Headquarters) Researchers from the Institute of Neuroscience and their collaborators revealed a new cellular mechanism for amyotrophic lateral sclerosis (ALS), suggested a novel therapeutic strategy targeting the RNA degradation pathway, and identified an asthma drug as a potential medication for ALS. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 9, 2019 Category: International Medicine & Public Health Source Type: news

In the Loop: Sandra Murphy-Pak and the Xavier Project -- creating the future of living with ALS
Sandra Murphy-Pak is not taking?amyotrophic lateral sclerosis, or ALS, lying down. Far from it, in fact. As?we noted?this past January, she's not letting the disease stand in the way of?her life as an artist. She's also helping to create "better therapies, if not a cure,?for those diagnosed with ALS in the future" by continually donating [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 9, 2019 Category: Databases & Libraries Source Type: news

Blacks Live Longer, Not Necessarily Better, With ALS
FRIDAY, April 5, 2019 -- Black Americans with amyotrophic lateral sclerosis (ALS) tend to live longer than whites with the disease because blacks are more likely to have a procedure called a tracheostomy, a new study shows. But that may not always... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 5, 2019 Category: General Medicine Source Type: news

Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis
Paralysis occurring in amyotrophic lateral sclerosis (ALS) results from denervation of skeletal muscle as a consequence of motor neuron degeneration. Interactions between motor neurons and glia contribute to motor neuron loss, but the spatiotemporal ordering of molecular events that drive these processes in intact spinal tissue remains poorly understood. Here, we use spatial transcriptomics to obtain gene expression measurements of mouse spinal cords over the course of disease, as well as of postmortem tissue from ALS patients, to characterize the underlying molecular mechanisms in ALS. We identify pathway dynamics, distin...
Source: ScienceNOW - April 4, 2019 Category: Science Authors: Maniatis, S., Äijö, T., Vickovic, S., Braine, C., Kang, K., Mollbrink, A., Fagegaltier, D., Andrusivova, Z., Saarenpää, S., Saiz-Castro, G., Cuevas, M., Watters, A., Lundeberg, J., Bonneau, R., Phatnani, H. Tags: Molecular Biology, Neuroscience reports Source Type: news

Lauren Sciences LLC wins AU$1 million grant award from FightMND
(Lauren Sciences LLC) Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart ® Nanomedicines for brain diseases, today announced it was awarded an AU$1 million translational grant from FightMND. The FightMND grant will advance Lauren Sciences development of LAUR-301, its novel V-Smart ® Nanomedicine for ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig's disease, or motor neuron disease (MND). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 2, 2019 Category: International Medicine & Public Health Source Type: news

Transplanted bone marrow endothelial progenitor cells delay ALS disease progression
(University of South Florida (USF Innovation)) Transplanting human bone marrow-derived endothelial progenitor cells into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier, University of South Florida researchers report. The new research, published recently in Scientific Reports, contributes to a growing body of work exploring cell therapy approaches to barrier repair in ALS and other neurodegenerative diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 2, 2019 Category: Biology Source Type: news

Nursing professor wins $6.575 million in grants to tackle musculoskeletal disease
(University of Texas at Arlington) Marco Brotto -- the George W. and Hazel M. Jay Professor in the college, and an internationally renowned scientist and an expert in bone, muscle physiology and sarcopenia -- recently obtained renewal for two grants, and funding for three new grants from the National Institutes of Health. These awards will further his work in tackling sarcopenia and osteoporosis, and support his new work on diabetic skeletal muscle disease and amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 15, 2019 Category: Biology Source Type: news

Playing Professional Soccer Linked to Increased ALS Risk Playing Professional Soccer Linked to Increased ALS Risk
Italian professional soccer players have a twofold increased risk for amyotrophic lateral sclerosis (ALS), and those who develop the disease do so at a relatively young age.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 4, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Are Soccer Pros at Higher Risk for ALS?
THURSDAY, Feb. 28, 2019 -- Professional soccer players may be vulnerable to amyotrophic lateral sclerosis (ALS), a new study suggests. The Italian researchers also found that soccer players may develop the neurodegenerative disease at a much younger... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 28, 2019 Category: General Medicine Source Type: news

Footballers are FIVE times more likely to get the condition that killed Professor Stephen Hawking
Hawking died in 2018 of amyotrophic lateral sclerosis, a neurological disease. Italian researchers found that footballers could develop ALS 21 years earlier than average. (Source: the Mail online | Health)
Source: the Mail online | Health - February 28, 2019 Category: Consumer Health News Source Type: news

AAN: Professional Soccer Players Show Increased Risk for ALS
THURSDAY, Feb. 28, 2019 -- Professional soccer players may have an increased risk for amyotrophic lateral sclerosis (ALS), according to a study scheduled for presentation at the upcoming annual meeting of the American Academy of Neurology, to be... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2019 Category: Pharmaceuticals Source Type: news

Could medical marijuana help grandma and grandpa with their ailments?
Medical marijuana may bring relief to older people who have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral sclerosis, Parkinson's disease, neuropathy, spinal cord damage and multiple sclerosis, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019. (Source: World Pharma News)
Source: World Pharma News - February 28, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Could medical marijuana help grandma and grandpa with their ailments?
(American Academy of Neurology) Medical marijuana may bring relief to older people who have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral sclerosis, Parkinson's disease, neuropathy, spinal cord damage and multiple sclerosis, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4-10, 2019. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 28, 2019 Category: International Medicine & Public Health Source Type: news